Protection for intellectual property will help stop industry R&D investment moving abroad, trade body says
Europe’s pharmaceutical industry is calling on the EU to adopt stronger protections for intellectual property in the bloc’s global trade deals, saying such a move would have economic benefits and increase drug companies’ spending on R&D.
“Intellectual property rights are increasingly important for knowledge-intensive economies,” the European Federation of Pharmaceutical Industries and Associations said in a blog post it published on 11 January. It added that IP protection is “essential for the EU’s strong export performance and for attracting investment in innovation”.